ABVC Annual FCF
-$4.26 M
+$3.26 M+43.38%
31 December 2023
Summary:
As of January 21, 2025, ABVC annual free cash flow is -$4.26 million, with the most recent change of +$3.26 million (+43.38%) on December 31, 2023. During the last 3 years, it has risen by +$306.90 thousand (+6.72%). ABVC annual FCF is now -17475.51% below its all-time high of $24.50 thousand, reached on December 31, 2006.ABVC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC Quarterly FCF
$171.70 K
+$1.19 M+116.93%
30 September 2024
Summary:
As of January 21, 2025, ABVC quarterly free cash flow is $171.70 thousand, with the most recent change of +$1.19 million (+116.93%) on September 30, 2024. Over the past year, it has increased by +$1.55 million (+112.44%). ABVC quarterly FCF is now -88.93% below its all-time high of $1.55 million, reached on December 31, 2006.ABVC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC TTM FCF
-$1.80 M
+$1.55 M+46.37%
30 September 2024
Summary:
As of January 21, 2025, ABVC TTM free cash flow is -$1.80 million, with the most recent change of +$1.55 million (+46.37%) on September 30, 2024. Over the past year, it has increased by +$2.44 million (+57.65%). ABVC TTM FCF is now -2624.75% below its all-time high of $71.10 thousand, reached on March 31, 2007.ABVC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.4% | +112.4% | +57.6% |
| 3 y3 years | +6.7% | +107.7% | +75.3% |
| 5 y5 years | -575.5% | +107.7% | +75.3% |
ABVC Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.1% | at high | +105.0% | at high | +84.1% |
| 5 y | 5-year | -35.8% | +44.1% | at high | +105.0% | at high | +84.1% |
| alltime | all time | <-9999.0% | +44.1% | -88.9% | +105.0% | -2624.8% | +84.1% |
ABVC BioPharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $171.70 K(-116.9%) | -$1.80 M(-46.4%) |
| June 2024 | - | -$1.01 M(+114.3%) | -$3.35 M(+3.5%) |
| Mar 2024 | - | -$473.20 K(-1.3%) | -$3.23 M(-24.1%) |
| Dec 2023 | -$4.26 M(-43.4%) | -$479.50 K(-65.3%) | -$4.26 M(+0.4%) |
| Sept 2023 | - | -$1.38 M(+53.4%) | -$4.24 M(+25.5%) |
| June 2023 | - | -$899.80 K(-39.9%) | -$3.38 M(-43.0%) |
| Mar 2023 | - | -$1.50 M(+224.7%) | -$5.93 M(-21.1%) |
| Dec 2022 | -$7.52 M(-1.3%) | -$461.20 K(-11.0%) | -$7.52 M(-21.5%) |
| Sept 2022 | - | -$518.10 K(-85.0%) | -$9.58 M(-15.2%) |
| June 2022 | - | -$3.45 M(+11.8%) | -$11.30 M(+21.6%) |
| Mar 2022 | - | -$3.09 M(+22.3%) | -$9.29 M(+22.0%) |
| Dec 2021 | -$7.62 M(+66.9%) | -$2.52 M(+13.0%) | -$7.62 M(+4.6%) |
| Sept 2021 | - | -$2.23 M(+54.7%) | -$7.28 M(+35.4%) |
| June 2021 | - | -$1.44 M(+2.2%) | -$5.37 M(+0.5%) |
| Mar 2021 | - | -$1.41 M(-35.4%) | -$5.35 M(+17.1%) |
| Dec 2020 | -$4.56 M(+45.6%) | -$2.19 M(+565.5%) | -$4.56 M(+17.9%) |
| Sept 2020 | - | -$328.80 K(-76.8%) | -$3.87 M(+2.3%) |
| June 2020 | - | -$1.42 M(+124.5%) | -$3.79 M(+19.6%) |
| Mar 2020 | - | -$630.90 K(-57.8%) | -$3.17 M(+1.0%) |
| Dec 2019 | -$3.13 M(+397.4%) | -$1.50 M(+517.6%) | -$3.13 M(+184.8%) |
| Sept 2019 | - | -$242.20 K(-69.6%) | -$1.10 M(+3.0%) |
| June 2019 | - | -$797.00 K(+32.9%) | -$1.07 M(+51.8%) |
| Mar 2019 | - | -$599.50 K(-211.4%) | -$704.20 K(+11.7%) |
| Dec 2018 | -$630.20 K(-57.6%) | $538.10 K(-355.9%) | -$630.20 K(-46.1%) |
| Sept 2018 | - | -$210.30 K(-51.4%) | -$1.17 M(-8.8%) |
| June 2018 | - | -$432.50 K(-17.7%) | -$1.28 M(+23.5%) |
| Mar 2018 | - | -$525.50 K(+62.6%) | -$1.04 M(-35.1%) |
| Dec 2017 | -$1.49 M(-7.1%) | - | - |
| Sept 2017 | - | -$323.20 K(+71.5%) | -$1.60 M(+7.5%) |
| Sept 2017 | -$1.60 M(-54.0%) | - | - |
| June 2017 | - | -$188.40 K(-78.1%) | -$1.49 M(-64.0%) |
| Mar 2017 | - | -$862.20 K(+283.4%) | -$4.13 M(+46.3%) |
| Dec 2016 | - | -$224.90 K(+6.4%) | -$2.83 M(-18.7%) |
| Sept 2016 | -$3.47 M(<-9900.0%) | -$211.40 K(-92.5%) | -$3.47 M(+6.5%) |
| June 2016 | - | -$2.83 M(-736.4%) | -$3.26 M(+666.7%) |
| Mar 2016 | - | $445.40 K(-150.9%) | -$425.50 K(-51.1%) |
| Dec 2015 | - | -$874.30 K(<-9900.0%) | -$870.90 K(<-9900.0%) |
| Sept 2015 | $3400.00(+183.3%) | $1100.00(-52.2%) | $3400.00(-2.9%) |
| June 2015 | - | $2300.00(>+9900.0%) | $3500.00(+191.7%) |
| Mar 2015 | - | $0.00(0.0%) | $1200.00(0.0%) |
| Dec 2014 | - | $0.00(-100.0%) | $1200.00(0.0%) |
| Sept 2014 | $1200.00 | $1200.00(>+9900.0%) | $1200.00(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2014 | - | $0.00(0.0%) | -$200.00(-85.7%) |
| Dec 2013 | - | $0.00(0.0%) | -$1400.00(-96.3%) |
| Sept 2013 | -$37.80 K(-96.0%) | $0.00(-100.0%) | -$37.80 K(-71.4%) |
| June 2013 | - | -$200.00(-83.3%) | -$132.00 K(-64.5%) |
| Mar 2013 | - | -$1200.00(-96.7%) | -$372.30 K(-36.5%) |
| Dec 2012 | - | -$36.40 K(-61.4%) | -$586.40 K(-37.3%) |
| Sept 2012 | -$934.70 K(-42.7%) | -$94.20 K(-60.8%) | -$934.70 K(-18.2%) |
| June 2012 | - | -$240.50 K(+11.7%) | -$1.14 M(-9.2%) |
| Mar 2012 | - | -$215.30 K(-44.0%) | -$1.26 M(-32.5%) |
| Dec 2011 | - | -$384.70 K(+27.6%) | -$1.86 M(+14.1%) |
| Sept 2011 | -$1.63 M(+54.2%) | -$301.60 K(-15.2%) | -$1.63 M(+8.1%) |
| June 2011 | - | -$355.60 K(-56.6%) | -$1.51 M(-1.7%) |
| Mar 2011 | - | -$820.20 K(+430.5%) | -$1.54 M(+91.7%) |
| Dec 2010 | - | -$154.60 K(-13.6%) | -$800.90 K(-24.3%) |
| Sept 2010 | -$1.06 M(-34.5%) | -$179.00 K(-53.1%) | -$1.06 M(-6.0%) |
| June 2010 | - | -$381.50 K(+344.6%) | -$1.13 M(+1.4%) |
| Mar 2010 | - | -$85.80 K(-79.2%) | -$1.11 M(-17.5%) |
| Dec 2009 | - | -$412.30 K(+67.5%) | -$1.35 M(-16.7%) |
| Sept 2009 | -$1.62 M(-36.7%) | -$246.20 K(-32.7%) | -$1.62 M(-24.0%) |
| June 2009 | - | -$365.70 K(+13.9%) | -$2.12 M(-1.4%) |
| Mar 2009 | - | -$321.10 K(-53.0%) | -$2.15 M(-14.9%) |
| Dec 2008 | - | -$682.50 K(-9.7%) | -$2.53 M(-0.8%) |
| Sept 2008 | -$2.55 M(-8.6%) | -$755.40 K(+90.8%) | -$2.55 M(+42.0%) |
| June 2008 | - | -$395.90 K(-43.3%) | -$1.80 M(-24.5%) |
| Mar 2008 | - | -$697.70 K(-0.7%) | -$2.38 M(+45.2%) |
| Dec 2007 | - | -$702.90 K(-28.1%) | -$1.64 M(+82.4%) |
| Sept 2007 | -$2.79 M(<-9900.0%) | - | - |
| June 2007 | - | -$977.80 K(-2368.7%) | -$898.00 K(-1363.0%) |
| Mar 2007 | - | $43.10 K(-97.2%) | $71.10 K(+190.2%) |
| Dec 2006 | $24.50 K(-233.2%) | $1.55 M(-202.4%) | $24.50 K(-101.6%) |
| Sept 2006 | - | -$1.51 M(>+9900.0%) | -$1.53 M(+6075.8%) |
| June 2006 | - | -$8700.00(+148.6%) | -$24.80 K(+32.6%) |
| Mar 2006 | - | -$3500.00(-30.0%) | -$18.70 K(+1.6%) |
| Dec 2005 | -$18.40 K(+148.6%) | -$5000.00(-34.2%) | -$18.40 K(-191.5%) |
| Sept 2005 | - | -$7600.00(+192.3%) | $20.10 K(+107.2%) |
| June 2005 | - | -$2600.00(-18.8%) | $9700.00(+506.3%) |
| Mar 2005 | - | -$3200.00(-109.6%) | $1600.00(-121.6%) |
| Dec 2004 | -$7400.00(-1950.0%) | $33.50 K(-286.1%) | -$7400.00(-81.9%) |
| Sept 2004 | - | -$18.00 K(+68.2%) | -$40.90 K(+78.6%) |
| June 2004 | - | -$10.70 K(-12.3%) | -$22.90 K(+87.7%) |
| Mar 2004 | - | -$12.20 K | -$12.20 K |
| Dec 2003 | $400.00 | - | - |
FAQ
- What is ABVC BioPharma annual free cash flow?
- What is the all time high annual FCF for ABVC BioPharma?
- What is ABVC BioPharma annual FCF year-on-year change?
- What is ABVC BioPharma quarterly free cash flow?
- What is the all time high quarterly FCF for ABVC BioPharma?
- What is ABVC BioPharma quarterly FCF year-on-year change?
- What is ABVC BioPharma TTM free cash flow?
- What is the all time high TTM FCF for ABVC BioPharma?
- What is ABVC BioPharma TTM FCF year-on-year change?
What is ABVC BioPharma annual free cash flow?
The current annual FCF of ABVC is -$4.26 M
What is the all time high annual FCF for ABVC BioPharma?
ABVC BioPharma all-time high annual free cash flow is $24.50 K
What is ABVC BioPharma annual FCF year-on-year change?
Over the past year, ABVC annual free cash flow has changed by +$3.26 M (+43.38%)
What is ABVC BioPharma quarterly free cash flow?
The current quarterly FCF of ABVC is $171.70 K
What is the all time high quarterly FCF for ABVC BioPharma?
ABVC BioPharma all-time high quarterly free cash flow is $1.55 M
What is ABVC BioPharma quarterly FCF year-on-year change?
Over the past year, ABVC quarterly free cash flow has changed by +$1.55 M (+112.44%)
What is ABVC BioPharma TTM free cash flow?
The current TTM FCF of ABVC is -$1.80 M
What is the all time high TTM FCF for ABVC BioPharma?
ABVC BioPharma all-time high TTM free cash flow is $71.10 K
What is ABVC BioPharma TTM FCF year-on-year change?
Over the past year, ABVC TTM free cash flow has changed by +$2.44 M (+57.65%)